SHILPAMED Share Price Target 2050

CAGR-based price projection for Shilpa Medicare Limited (SHILPAMED) targeting 2050, derived from official NSE exchange closing prices.

Bear Case (61.3% CAGR)
Rs 102,663,896
2050 Target
Base Case (153.3% CAGR)
Rs 5,177,221,223,816
2050 Target
Bull Case (704.1% CAGR)
Rs 5,676,026,164,377,656,158,584,832
2050 Target

Current Market Snapshot

CMP: Rs 1,064.10
52W High: Rs 1,070.80
52W Low: Rs 404.05
1Y CAGR: 541.6%
3Y CAGR: 153.3%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 1,717 Rs 2,695 Rs 8,556
2028 Rs 2,769 Rs 6,827 Rs 68,797
2029 Rs 4,467 Rs 17,293 Rs 553,178
2030 Rs 7,206 Rs 43,803 Rs 4,447,945
2031 Rs 11,625 Rs 110,951 Rs 35,764,626
2032 Rs 18,754 Rs 281,035 Rs 287,572,882
2033 Rs 30,254 Rs 711,854 Rs 2,312,289,341
2034 Rs 48,805 Rs 1,803,103 Rs 18,592,441,558
2035 Rs 78,731 Rs 4,567,203 Rs 149,496,378,713
2036 Rs 127,008 Rs 11,568,580 Rs 1,202,056,608,783
2037 Rs 204,887 Rs 29,302,847 Rs 9,665,385,229,783
2038 Rs 330,522 Rs 74,223,184 Rs 77,716,532,613,816
2039 Rs 533,194 Rs 188,004,976 Rs 624,895,883,394,557
2040 Rs 860,141 Rs 476,210,653 Rs 5,024,604,829,243,836
2041 Rs 1,387,569 Rs 1,206,226,507 Rs 40,401,376,230,734,144
2042 Rs 2,238,408 Rs 3,055,333,555 Rs 324,855,636,773,125,888
2043 Rs 3,610,972 Rs 7,739,063,165 Rs 2,612,069,057,761,290,240
2044 Rs 5,825,174 Rs 19,602,801,984 Rs 21,002,882,481,238,781,952
2045 Rs 9,397,097 Rs 49,653,276,819 Rs 168,878,028,400,518,496,256
2046 Rs 15,159,278 Rs 125,770,178,202 Rs 1,357,898,778,985,321,463,808
2047 Rs 24,454,756 Rs 318,571,879,612 Rs 10,918,466,489,890,438,643,712
2048 Rs 39,450,102 Rs 806,932,485,349 Rs 87,792,192,124,910,288,502,784
2049 Rs 63,640,405 Rs 2,043,934,438,610 Rs 705,911,311,376,337,640,357,888
2050 Rs 102,663,896 Rs 5,177,221,223,816 Rs 5,676,026,164,377,656,158,584,832

Other SHILPAMED Price Targets

2025 2026 2027 2028 2030 2035 2040

Frequently Asked Questions

What is the SHILPAMED share price target for 2050?

Based on historical growth analysis, the SHILPAMED share price target for 2050 ranges from Rs 102,663,896 (conservative) to Rs 5,177,221,223,816 (base case) to Rs 5,676,026,164,377,656,158,584,832 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of SHILPAMED?

The current market price of SHILPAMED (Shilpa Medicare Limited) is Rs 1,064.10. The 52-week high is Rs 1,070.80 and 52-week low is Rs 404.05.

Is SHILPAMED a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for SHILPAMED price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 61.3% CAGR), Base (153.3% CAGR), and Bull (optimistic at 704.1% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.